Singapore: Zimmer Holdings, a global leader in musculoskeletal health, has signed a memorandum of understanding (MoU), w...
Mumbai: Cipla launched the first biosimilar of Etanercept in India under the brand name, Etacept, indicated for the trea...
Singapore: Cellular Biomedicine appointed Dr Jianping Dai to the board of directors. Dr Dai is a professor of radiology...
Singapore: DelMar Pharmaceuticals announced that the Chinese Bureau of Foreign Experts has approved the application for ...
Singapore: BioMed Innovation Summit 2013 will launch on March 14-15, 2013, in Shanghai, China, in order to promote the ...
Singapore: TranScrip Partners, a UK-based specialist contract research organization (CRO) that started its operation in ...
Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined...
Singapore: China Cord Blood (CCB), which is the first and largest cord blood banking operator in China, highlighted that...
Singapore: GlaxoSmithKline's former China head Mr Mark Reilly would be returning to China shortly to assist the police w...
Singapore: 3SBio, a leading China-based biotechnology company focused on R&D, manufacturing and marketing biopharma...
Pharmaceutical companies in the region are starting to take more interest in biologics and biosimilars, and of course wi...
Singapore: China Cord Blood, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem c...
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...
Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...
Singapore: The business heads of Johnson & Johnson's (J&J) three Chinese operations would report to one local ch...
Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...
Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF1...
Singapore: X-Change, a US-based boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions ...
